Accessibility Menu
Resverlogix logo

Resverlogix

(TSX) RVX

Current PriceCA$0.10
Market CapCA$30.11M
Since IPO (2003)-94%
5 Year-90%
1 Year+111%
1 Month+0%

Resverlogix Financials at a Glance

Market Cap

CA$30.11M

Revenue (TTM)

$0.00

Net Income (TTM)

-$6.52M

EPS (TTM)

-CA$0.03

P/E Ratio

-3.25

Dividend

CA$0.00

Beta (Volatility)

-0.02 (Low)

Price

CA$0.10

Volume

4,500

Open

CA$0.10

Previous Close

CA$0.10

Daily Range

CA$0.10 - CA$0.10

52-Week Range

CA$0.04 - CA$0.30

RVX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Resverlogix

Industry

Biotechnology

Employees

17

CEO

Donald J. McCaffrey

Headquarters

Calgary, AB T3E 6L1, CA

RVX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

14%

Return on Assets

-82%

Earnings Yield

-30.77%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$30.11M

Shares Outstanding

316.98M

Volume

4.50K

Avg. Volume

35.40K

Financials (TTM)

Gross Profit

-$437.53K

Operating Income

-$5.20M

EBITDA

-$4.77M

Operating Cash Flow

-$3.73M

Capital Expenditure

-$9.16K

Free Cash Flow

-$3.73M

Cash & ST Invst.

$107.80K

Total Debt

$72.77M

Resverlogix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$78.69K

+47.3%

Gross Margin

0.00%

N/A

Market Cap

CA$30.11M

N/A

Market Cap/Employee

CA$1.58M

N/A

Employees

19

N/A

Net Income

-$3.39M

+32.1%

EBITDA

-$1.08M

-6.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

-$75.01M

-330.5%

Accounts Receivable

$855.60K

+31.8%

Inventory

$435.31K

-53.5%

Long Term Debt

$53.24M

+554.7%

Short Term Debt

$21.82M

+131.0%

Return on Assets

-81.57%

N/A

Return on Invested Capital

14.20%

N/A

Free Cash Flow

-$972.79K

+16.2%

Operating Cash Flow

-$972.79K

-4.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LABS.TOMediPharm Labs Corp.
CA$0.08+0.00%
MBX.TOMicrobix Biosystems Inc.
CA$0.27-1.82%
AVCN.TOAvicanna Inc.
CA$0.13-3.85%
BCT.TOBriaCell Therapeutics Corp.
CA$5.03+0.80%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCEVirgin Galactic
$6.18+0.36%
SOFISoFi Technologies
$18.22+0.07%
ONDSOndas
$13.22-0.00%
NOKNokia
$14.84-0.03%

Questions About RVX

What is the current price of Resverlogix?

Resverlogix is trading at CA$0.10 per share.

What is the 52-week range for Resverlogix?

Over the past 52 weeks, Resverlogix has traded between CA$0.04 and CA$0.30.

How much debt does Resverlogix have?

As of the most recent reporting period, Resverlogix reported total debt of $104.67M.

How much cash does Resverlogix have on hand?

Resverlogix reported $69.78K in cash and cash equivalents in its most recent financial results.

What is Resverlogix’s dividend yield?

Resverlogix does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.